A Phase 3 Randomızed, Open-Label, Multıcenter Study Of Isatuxımab, Pomalıdomıde, And Low-Dose Dexamethasone Vs Pomalıdomıde And Low-Dose Dexamethasone In Relapsed/Refractory Multıple Myeloma (Rrmm)

Attal M., Richardson P., Rajkumar S., SanMiguel J., BEKSAÇ M., Spicka I., ...More

24 Congress of the European Hematology Association, 13 - 16 June 2019, (Full Text)

  • Publication Type: Conference Paper / Full Text
  • Ankara University Affiliated: Yes